BackgroundCheck.run
Search For

Jaime G Guzman, 5310103 W Lyndale Ave, Melrose Park, IL 60164

Known as:
Jamie Guzman
Related to:
Juan Guzman

Jaime Guzman Phones & Addresses

10103 W Lyndale Ave, Melrose Park, IL 60164    847-4511603   

Stone Park, IL   

Hillside, IL   

Franklin Park, IL   

PO Box 1063, Melrose Park, IL 60161   

Work

Position: Food Preparation and Serving Related Occupations

Education

Degree: Associate degree or higher
Get Report
Control this profile

Mentions for Jaime G Guzman

Career records & work history

License Records

Jaime A Guzman

Licenses:
License #: 06NAR3979 - Expired
Category: Nursing Assistant
Type: Not Licensed - REGISTRY ONLY

Jaime A Guzman

Licenses:
License #: 033629-24 - Expired
Category: Nursing Assistant
Issued Date: May 16, 2006
Expiration Date: Nov 24, 2011
Type: Licensed Nursing Assistant

Jaime Guzman

Licenses:
License #: 50047 - Active
Category: Professional
Issued Date: Jul 27, 2009
Expiration Date: Sep 30, 2018

Publications & IP owners

Us Patents

Treatment For Dopaminergic Disorders

US Patent:
2020032, Oct 15, 2020
Filed:
Feb 12, 2020
Appl. No.:
16/788463
Inventors:
- Evanston IL, US
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US
International Classification:
A61K 31/4439
A61K 31/135
Abstract:
The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Methods And Compositions For Modulating Calcium Channels

US Patent:
2018028, Oct 4, 2018
Filed:
Jun 7, 2018
Appl. No.:
16/002626
Inventors:
- Evanston IL, US
Michelle Day - Chicago IL, US
Jun Ding - Chicago IL, US
C. Savio Chan - Chicago IL, US
Jaime Guzman - Wilmette IL, US
Jeff Mercer - Chicago IL, US
Tatiana Tkatch - Chicago IL, US
Zhongfeng Wang - Evanston IL, US
Ema Ilijic - Chicago IL, US
International Classification:
A61K 31/4439
Abstract:
The present invention relates to methods and compositions for modulating calcium channels. In particular, the present invention provides methods and compositions for modulating (e.g., disrupting) Cav1.3a calcium channels for research and therapeutic methods (e.g., treating dopaminergic diseases and conditions).

Methods And Compositions For Modulating Calcium Channels

US Patent:
2018006, Mar 8, 2018
Filed:
Sep 2, 2016
Appl. No.:
15/255674
Inventors:
- Evanston IL, US
Michelle Day - Chicago IL, US
Jun Ding - Chicago IL, US
C. Savio Chan - Chicago IL, US
Jaime Guzman - Wilmette IL, US
Jeff Mercer - Chicago IL, US
Tatiana Tkatch - Chicago IL, US
Zhongfeng Wang - Evanston IL, US
Ema Ilijic - Chicago IL, US
International Classification:
A61K 31/4439
Abstract:
The present invention relates to methods and compositions for modulating calcium channels. In particular, the present invention provides methods and compositions for modulating (e.g., disrupting) Cav1.3a calcium channels for research and therapeutic methods (e.g., treating dopaminergic diseases and conditions).

Treatment For Dopaminergic Disorders

US Patent:
2017018, Jun 29, 2017
Filed:
Oct 11, 2016
Appl. No.:
15/290035
Inventors:
- Evanston, IL
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US
International Classification:
A61K 31/4439
A61K 31/135
Abstract:
The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Treatment For Dopaminergic Disorders

US Patent:
2014030, Oct 16, 2014
Filed:
Apr 15, 2014
Appl. No.:
14/253528
Inventors:
- Evanston IL, US
Javier Sanchez - Chicago IL, US
Jaime Guzman - Chicago IL, US
Enrico Zampese - Chicago IL, US
Daniel Galtieri - Chicago IL, US
Ema Ilijic - Chicago IL, US
Assignee:
Northwestern University - Evanston IL
International Classification:
A61K 31/4439
A61K 31/135
US Classification:
514338
Abstract:
The present invention provides systems, compositions and methods for treatment of dopaminergic disorders (e.g., Parkinson's disease) using the combination of a first compound that inhibits a voltage-gated calcium channel of the type Ca1.3 (e.g., a dihydropyridine such as isradipine), and a second compound that is monoamine oxidase inhibitor and/or is a nitric oxide synthase inhibitor (e.g., rasagiline or derivative thereof).

Possible Relatives

David V Guzman  Dagoberto Guzman  Daiana S Guzman  Daisy Guzman  Debbie C Guzman  Dalia Guzman  Dalila O Guzman  Jaime M Johnson  Jaime L Johnston  Jaime R White 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.